Literature DB >> 21491150

A new exact test for the evaluation of population pharmacokinetic and/or pharmacodynamic models using random projections.

Celine Marielle Laffont1, Didier Concordet.   

Abstract

PURPOSE: Within-subject dependency of observations has a strong impact on the evaluation of population pharmacokinetic (PK) and/or pharmacodynamic (PD) models. To our knowledge, none of the current model evaluation tools correctly address this issue. We present a new method with a global test and easy diagnostic plot which relies on the use of a random projection technique that allows the analysis of dependent data.
METHODS: For each subject, the vector of standardised residuals is calculated and projected onto many random directions drawn uniformly from the unit sphere. Our test compares the empirical distribution of projections with their distribution under the model. Simulation studies assess the level of the test and compare its performance with common metrics including normalised prediction distribution errors and different types of weighted residuals. An application to real data is performed.
RESULTS: In contrast to other evaluated methods, our test shows adequate level for all models and designs investigated, which confirms its good theoretical properties. The weakness of other methods is demonstrated and discussed.
CONCLUSIONS: This new test appears promising and could be used in combination with other tools to drive model evaluation in population PK/PD analyses.

Entities:  

Mesh:

Year:  2011        PMID: 21491150     DOI: 10.1007/s11095-011-0422-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Model-based drug development: the road to quantitative pharmacology.

Authors:  Liping Zhang; Vikram Sinha; S Thomas Forgue; Sophie Callies; Lan Ni; Richard Peck; Sandra R B Allerheiligen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-13       Impact factor: 2.745

2.  Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.

Authors:  Karl Brendel; Emmanuelle Comets; Céline Laffont; Christian Laveille; France Mentré
Journal:  Pharm Res       Date:  2006-08-12       Impact factor: 4.200

3.  3-D object recognition using 2-D views.

Authors:  Wenjing Li; George Bebis; Nikolaos G Bourbakis
Journal:  IEEE Trans Image Process       Date:  2008-11       Impact factor: 10.856

4.  The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.

Authors:  Hanna E Silber; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-02-14       Impact factor: 2.745

5.  Evaluation of different tests based on observations for external model evaluation of population analyses.

Authors:  Karl Brendel; Emmanuelle Comets; Céline Laffont; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-23       Impact factor: 2.745

6.  Robust classifiers for data reduced via random projections.

Authors:  Angshul Majumdar; Rabab K Ward
Journal:  IEEE Trans Syst Man Cybern B Cybern       Date:  2010-01-26

7.  Fuzzy ensemble clustering based on random projections for DNA microarray data analysis.

Authors:  Roberto Avogadri; Giorgio Valentini
Journal:  Artif Intell Med       Date:  2008-09-17       Impact factor: 5.326

8.  RAP: a computer program for exploring similarities in behavior sequences using random projections.

Authors:  Vicenç Quera
Journal:  Behav Res Methods       Date:  2008-02

Review 9.  The role of population pharmacokinetics in drug development in light of the Food and Drug Administration's 'Guidance for Industry: population pharmacokinetics'.

Authors:  P J Williams; E I Ette
Journal:  Clin Pharmacokinet       Date:  2000-12       Impact factor: 6.447

10.  Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.

Authors:  Y Yano; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-04       Impact factor: 2.745

View more
  3 in total

1.  Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.

Authors:  Thi Huyen Tram Nguyen; Emmanuelle Comets; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-11       Impact factor: 2.745

2.  Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions.

Authors:  Marc Lavielle; Benjamin Ribba
Journal:  Pharm Res       Date:  2016-09-07       Impact factor: 4.200

3.  Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.

Authors:  T H T Nguyen; M-S Mouksassi; N Holford; N Al-Huniti; I Freedman; A C Hooker; J John; M O Karlsson; D R Mould; J J Pérez Ruixo; E L Plan; R Savic; J G C van Hasselt; B Weber; C Zhou; E Comets; F Mentré
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.